Effect of Delayed Cord Clamping in Preterm Neonates With Placental Insufficiency
- Conditions
- Preterm InfantPlacental InsufficiencyPlacental Transfusion
- Interventions
- Procedure: Delayed cord clamping
- Registration Number
- NCT03731546
- Lead Sponsor
- Mansoura University Children Hospital
- Brief Summary
To investigate the effect of delayed cord clamping (DCC) on hematopoietic progenitor cells (HPCs), hematological parameters including haemoglobin concentration and hematocrit value in premature infants (34 weeks gestational age or less) with placental insufficiency.We hypothesized that preterm infants with placental insufficiency underwent DDC could have better hematologic parameters and hematopoietic progenitor cells compared to immediate cord clamping.
- Detailed Description
• A prospective randomized controlled study will be performed on preterm infants 34 weeks gestational age or less with placental insufficiency, and those without placental insufficiency where DCC will be performed in both groups. A third group of preterm with placental insufficiency and immediate cord clamping will be performed as a control.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- preterm neonates < 34 weeks gestational age
- Vaginal bleeding due to placental abruption or tears Multiple pregnancies Suspected major fetal anomalies Suspected chromosomal aberration Maternal drug abuse Hydrops fetalis preterm who needed major resuscitative measures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group B Delayed cord clamping Placental insufficiency and DCC: Cord clamping 60 seconds after delivery of fetus in preterm infants with placental insufficiency Group C Delayed cord clamping Normal placenta with DCC:Cord clamping 60 seconds after delivery of fetus in preterm infants without placental insufficiency
- Primary Outcome Measures
Name Time Method Peripheral venous CD34 at admission first 24 hours of infants' life One milliliter of fetal blood will be taken from peripheral venous blood in the first 30 minutes of life and CD34 will be assessed by flow cytometry.
- Secondary Outcome Measures
Name Time Method Hemoglobin at 2 months 2 months of infants' life One milliliter of neonatal blood will be taken from peripheral venous blood at 2 months of life.
Intraventricular hemorrhage first 28 days of life Retinopathy of prematurity first 28 days of life Admission hemoglobin first 24 hours of infants' life One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.
Polycythemia first 28 days of life Necrotizing enterocolitis first 28 days of life Duration of oxygen therapy first 28 days of life Bronchopulmonary dysplasia first 70 days of life Need for nasal CPAP first 28 days of life Admission platelets first 24 hours of infants' life One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.
Culture proven sepsis first 28 days of life Need for mechanical ventilation first 28 days of life Need for inotropes first 28 days of life Need for packed RBCs transfusion first 28 days of life Admission WBCs first 24 hours of infants' life One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24
Phototherapy requirements first 28 days of life
Trial Locations
- Locations (1)
Mansoura University Children's Hospital
🇪🇬Mansourah, Egypt